1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Effect of GLP1 Receptor Agonist on Brain Insulin ResponsivenessBody Weight, Insulin Resistance, Insulin Sensitivity, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, glucose metabolism disease, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutritionRecruitingNot applicable2025-03-30NCT06487832